文献速递主动脉外科

近端主动脉瘤修复中半弓置换的长期结局:逾1000例患者分析

Long-term outcome of hemiarch replacement in a proximal aortic aneurysm repair: analysis of over 1000 patients.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

回顾性分析2005至2019年1132例近端主动脉瘤修复患者,倾向评分2:1匹配后比较半弓与非半弓组。半弓组10年生存率显著更低(73.8% vs 86.5%,P<0.001),主要由院内死亡率较高驱动(4% vs 1%);两组主动脉弓再干预率均低且无显著差异。多变量分析显示半弓与长期死亡率独立相关(HR 2.16),与再干预无关。

要点

  • 半弓组10年生存率73.8%低于非半弓组86.5%,差异显著(P<0.001)。
  • 半弓组院内死亡率4%高于非半弓组1%(P<0.001)。
  • 10年主动脉弓再干预率两组均低且无显著差异(1.0% vs 1.3%,P=0.615)。

核心结论

  • 半弓修复可能与较高的短期死亡率相关。
  • 无弓部动脉瘤的近端胸主动脉瘤修复后弓部再干预罕见。
  • 作者呼吁开展更大规模前瞻性研究以进一步明确半弓修复在近端主动脉手术中的效用。

研究设计与样本

  • 回顾性 review,纳入2005至2019年在本主动脉中心接受近端主动脉瘤修复的1132例患者。
  • 纳入标准为接受根部或升主动脉瘤修复伴或不伴半弓置换的所有患者。
  • 排除标准为年龄<18岁、主动脉弓直径≥4.5 cm、A型主动脉夹层、既往升主动脉置换、破裂动脉瘤和心内膜炎。
  • 按19项基线特征进行2:1倾向评分匹配(573例非半弓:288例半弓)。
  • 中位随访时间46.8个月(范围0.1-170.4个月)。

主要发现

  • 匹配队列中半弓组10年生存率显著低于非半弓组(半弓73.8%;66.9-81.4% vs 非半弓86.5%;81.1-92.3%;P < 0.001)。
  • 半弓组院内死亡率4%高于非半弓组1%(P < 0.001)。
  • 10年主动脉弓累积再干预率两组均低且无显著差异(半弓1.0%;0-2.5% vs 非半弓1.3%;0-2.6%,P = 0.615)。
  • 总体队列多变量分析显示半弓是长期死亡率的独立相关因素(HR 2.16;1.42-3.27;P < 0.001),但与主动脉弓再干预无关(HR 0.76;0.14-4.07,P = 0.750)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to investigate the impact of hemiarch replacement in patients undergoing an open repair of proximal thoracic aortic aneurysm without arch aneurysm. METHODS: A retrospective review was performed on 1132 patients undergoing proximal aortic aneurysm repair at our Aortic Center between 2005 and 2019. Inclusion criteria were all patients undergoing root or ascending aortic aneurysm repair with or without hemiarch replacement. Exclusion criteria were age <18 years, aortic arch diameter ≥4.5 cm, type A aortic dissection, previous ascending aortic replacement, ruptured aneurysm and endocarditis. Propensity score matching in a 2:1 ratio (573 non-hemiarch: 288 hemiarch) on 19 baseline characteristics was performed. The median follow-up time was 46.8 months (range 0.1-170.4 months). RESULTS: Hemiarch patients had significantly lower 10-year survival in the matched cohort (hemiarch 73.8%; 66.9-81.4%; vs non-hemiarch 86.5%; 81.1-92.3%; P < 0.001), driven by higher in-hospital mortality rate (4% vs 1%; P < 0.001). Cumulative incidence of aortic arch reintervention rates at 10 years was similarly low (hemiarch 1.0%; 0-2.5% vs non-hemiarch 1.3%; 0-2.6%, P = 0.615). Multivariate analysis with hazard ratios of the overall cohort showed hemiarch as an independent factor associated with long-term mortality (2.16; 1.42-3.27; P < 0.001) but not with aortic arch reintervention (0.76; 0.14-4.07, P = 0.750). CONCLUSIONS: Hemiarch repair may be associated with higher short-term mortality compared to non-hemiarch. Arch reintervention was rare after a repair of proximal thoracic aortic aneurysm without arch aneurysm. Our data call for larger and prospective studies to further delineate the utility of hemiarch repair in proximal aortic surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pearsall C, Blitzer D, Zhao Y, et al. Long-term outcome of hemiarch replacement in a proximal aortic aneurysm repair: analysis of over 1000 patients. Eur J Cardiothorac Surg. 2022. PMID: 35134153. doi:10.1093/ejcts/ezab571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。